Safety and Efficacy of TRC4186 in the treatment of stable heart failure associated with HbA1C 6.0% or type 2 Diabetes receiving oral hypoglycaemic therapy (with or without additional insulin) as an add-on to conventional treatment for heart failure

Status: Completed

Phase of Trial: Phase II

Latest Information Update: 07 Apr 2022

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs TRC 4186 (Primary)
Indications Chronic heart failure
Focus Adverse reactions; Proof of concept; Therapeutic Use
Sponsors Torrent Pharmaceuticals

Most Recent Events

11 Apr 2012 Status changed from recruiting to completed as reported by Clinical Trials Registry - India record.
26 Jun 2010 Planned number of patients changed from 230 to 300 as reported by Clinical Trials Registry - India.
08 Feb 2010 New trial record

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com

Welcome to AdisInsight